Citation Impact
Citing Papers
The Somatomedin Hypothesis: 2001
2001
What is polypharmacy? A systematic review of definitions
2017 Standout
Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
2018
Comprehensive discharge follow-up in patients’ homes by GPs and district nurses of elderly patients
2010
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials
2019
Data Resource Profile: The Danish National Prescription Registry
2016 Standout
Impact of harm reduction practice on the use of non-prescribed performance and image-enhancing drugs (PIEDs): The PUSH! Audit
2023 StandoutNobel
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
2018
Diabetes Mellitus and Heart Failure
2017
Physicians’ and pharmacies’ overview of patients’ medication. An analysis of fidelity coefficients
2011
Potentially inappropriate medication related to weakness in older acute medical patients
2014
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
The Somatomedin Hypothesis: 2001
2001
Partial Deletion of Pten in the Hypothalamus Leads to Growth Defects that Cannot be Rescued by Exogenous Growth Hormone
2008 StandoutNobel
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
2017
Diabetic Cardiomyopathy
2018 Standout
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Baseline characteristics of the HAARLEM study: 100 male amateur athletes using anabolic androgenic steroids
2019
Interventions for enhancing medication adherence
2014 Standout
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?
2019
Works of Jon Rasmussen being referenced
Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial
2016
Congruence on medication between patients and physicians involved in patient course
2004
Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study
2016
Effects of growth hormone on rat renal epidermal growth factor expression
1994